Skip to main content

Bacteriophage Therapy Market Increase In Transactional And Analytical Needs Across Several Industries 2028

 


Market Size and Analysis

Worldwide, the prevalence of antibiotic resistance is rising, increasing the necessity for efficient substitutes. The CDC estimates that 33 000 persons in Europe are afflicted with antibiotic-resistant bacterial illnesses each year. There will likely be a significant increase in bacterial phage demand as antibiotic resistance is projected to spread globally. Bacteriophage therapy is also known as phage therapy. Viral agents are used to treat bacterial illnesses. The bacterial viruses known as bacteriophages. Phages are viruses that kill bacteria but are safe for plants, animals, and people. The natural enemies of bacteria are assumed to be bacteriophages. Sewage, water, soil, and other places where bacteria are present are home to bacteriophages.

The global bacteriophage therapy market is estimated to be valued at US$ 1,148.6 million in 2020 and is expected to exhibit a CAGR of 3.7% over the forecast period (2020-2030).

Important Factors Driving the Global Bacteriophages Therapy Market

  • Food deterioration contributes to a rise in the occurrence of foodborne illnesses. Viral and bacterial pathogens can be found in spoiled food. According to the WHO, over 600 million individuals (almost 1 in 10 people worldwide) will become unwell in 2019 after eating contaminated food, and 420,000 will die as a result. This will result in the loss of 33 million years of healthy life (DALYs). Additionally, 125,000 deaths annually from foodborne diseases are caused by children under the age of five. This element is accelerating the market for bacteriophages therapy.
  • Bacteriophages attack microorganisms with extreme specificity. Its application is focused on a specific bacterial species, which considerably reduces any unintended effects on the microbiome or humans.

Labels:

Comments

Post a Comment

Popular posts from this blog

Virology Testing Market Detailed In New Research Report 2023

  Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified. Virology Testing Market- Market Dynamics Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course. According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual...
Post a Comment
Read more

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering ...
Post a Comment
Read more

Autologous Stem Cell and Non-Stem Cell Based Therapies Market Analysis

  A primary driver for this market is the worldwide increase in occurrence of diabetes and cancer, across all age groups. According to the World Health Organization (WHO) 2018 statistics, the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Moreover according to the World Health Organization cancer factsheet 2018, Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.  Furthermore, increasing old age population is another driver, which is anticipated to create a high growth scenario for the market. As per the World Population Prospects 2019 revision, the number of people aged 80 years or over is projected to be triple, from 143 million in 2019 to 426 million in 2050. Alternatively, factors restraining the market are complications and risks associated with the treatment including diarrhea, nausea, hair loss, vomiting, severe infections, infertility, and heart complications....
Post a Comment
Read more